A novel latent membrane 2 transcript expressed in Epstein-Barr virus–positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy

MLA

Tracey A. Haigh, et al. “A Novel Latent Membrane 2 Transcript Expressed in Epstein-Barr Virus–positive NK- and T-Cell Lymphoproliferative Disease Encodes a Target for Cellular Immunotherapy.” Blood, vol. 116, Nov. 2010, pp. 3695–704. EBSCOhost, https://doi.org/10.1182/blood-2010-06-292268.

APA

Tracey A. Haigh, Wing C. Chan, Andrew I. Bell, Simon O’Connor, Alan B. Rickinson, Heather M. Long, Catherine M. Bollard, Martin Rowe, Javeed Iqbal, Christopher P. Fox, Claire Shannon-Lowe, Steven P. Lee, & Graham S. Taylor. (2010). A novel latent membrane 2 transcript expressed in Epstein-Barr virus–positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy. Blood, 116, 3695–3704. https://doi.org/10.1182/blood-2010-06-292268

Chicago

Tracey A. Haigh, Wing C. Chan, Andrew I. Bell, Simon O’Connor, Alan B. Rickinson, Heather M. Long, Catherine M. Bollard, et al. 2010. “A Novel Latent Membrane 2 Transcript Expressed in Epstein-Barr Virus–positive NK- and T-Cell Lymphoproliferative Disease Encodes a Target for Cellular Immunotherapy.” Blood 116 (November): 3695–3704. doi:10.1182/blood-2010-06-292268.